Forte Biosciences (FBRX) Reports Q2 Loss of $0.42/sh
Tweet
Share
E-mailGet Alerts FBRX Hot Sheet
Join SI Premium – FREE
Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($0.42), versus ($0.21) reported last year.
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
- Pan American Silver (PAAS) Misses Q2 EPS by 19c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
